End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,060 KRW | -0.81% | +3.90% | +2.00% |
Business Summary
Number of employees: 238
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 51,642 | 87.4 % | 71,318 | 100.0 % | +38.10% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
96.1
%
| 54,624 | 92.5 % | 68,514 | 96.1 % | +25.43% |
Others
1.7
%
| 2,380 | 4.0 % | 1,227 | 1.7 % | -48.44% |
China
1.2
%
| 449 | 0.8 % | 886 | 1.2 % | +97.42% |
Russia
0.4
%
| 218 | 0.4 % | 277 | 0.4 % | +27.08% |
Japan
0.4
%
| 1,073 | 1.8 % | 264 | 0.4 % | -75.39% |
Vietnam
0.2
%
| 323 | 0.5 % | 149 | 0.2 % | -53.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dong-Hoon Oh
CEO | Chief Executive Officer | 52 | - |
Jae-Gwan Han
CEO | Chief Executive Officer | 58 | 13-07-31 |
Seung-Rak Hong
DFI | Director of Finance/CFO | 51 | - |
Chan-Hui Han
AUD | Comptroller/Controller/Auditor | 60 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jae-Gwan Han
CEO | Chief Executive Officer | 58 | 13-07-31 |
Yoon-Chul Lee
BRD | Director/Board Member | 53 | 20-01-19 |
Dong-Hoon Oh
CEO | Chief Executive Officer | 52 | - |
Byung-Gi Kim
BRD | Director/Board Member | 55 | - |
Hyun-Seok Lee
BRD | Director/Board Member | 52 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 48,211,715 | 28,897,500 ( 59.94 %) | 725,221 ( 1.504 %) | 59.94 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+2.00% | 106M | |
+40.73% | 734B | |
+32.83% | 591B | |
-6.30% | 350B | |
+15.15% | 315B | |
+4.05% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+6.17% | 161B |
- Stock Market
- Equities
- A082800 Stock
- Company Vivozon Pharmaceutical Co., Ltd.